SPL 0.00% 9.5¢ starpharma holdings limited

Is a Peer Review required for Viraleze covid viral load claim?, page-21

  1. 9,338 Posts.
    lightbulb Created with Sketch. 846
    I know what you are saying and I'll keep my skeptic and cynical hat on ( especially considering SPL communications) for now as my conspiracy one has never fitted. Authorities IMO have a distinct dislike of underpowered and broken trials so I am not getting positive vibes . Odds of a further trial by SPL to harden data if required - very slim

    Peer review and publishing - well I wonder if anything other than a summary at required 12 months will happen. Yep only 3 months away - that will probably trigger a KPI or 10 as a chrissy gift

    Product has great promise in a niche post covid era ( not the category killer some SPL holder believe) but will take real data to prove to market its value and need signals that management are capable can actually do anything with it IMO. The opportunity and potential lost by SPL is astonishing.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.